SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Czaja AJ. Autoimmune liver disease. In: ZakimD, BoyerTD, eds. Hepatology: A Textbook of Liver Disease, 4th ed. Philadelphia: Saunders, 2003: 12591292.
  • 2
    Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995; 333: 958963.
  • 3
    Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354: 5466.
  • 4
    Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929938.
  • 5
    Walker JG, Doniach D, Roitt IM, Sherlock S. Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1965; 17: 827831.
  • 6
    O'Grady JG. Acute liver failure. In: BaconBR, Di BisceglieAM, O'GradyJG, DiBisceglieAM, LakeJR, eds. Comprehensive clinical hepatology, 2nd ed. Philadelphia: Mosby, 2006: 517536.
  • 7
    Trey C, Davidson CS. In: PopperH, ShaffnerF, eds. Progress in liver diseases: the management of fulminant hepatic failure. New York: Grune and Stratton, 1970; 3: 282298.
  • 8
    Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johan M, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995; 222: 109119.
  • 9
    Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6: 648651.
  • 10
    Bernuau J, Samuel D, Durand F. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal: a prospective study. Hepatology 1991; 14: 49A
  • 11
    Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002; 26: 103110.
  • 12
    Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999; 23: 319330.
  • 13
    Crean JM, Niederman MS, Fein AM, Feinsilver SH. Rapidly progressive respiratory failure due to aspergillus pneumonia: a complication of short-term corticosteroid therapy. Crit Care Med 1992; 20: 148150.
  • 14
    Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004; 2: 625631.
  • 15
    Abe M, Hiasa Y, Masumoto T, Kumagi T, Akbar SM, Ninomiya T, et al. Clinical characteristics of autoimmune hepatitis with histological features of acute hepatitis. Hepatol Res 2001; 21: 213219.
  • 16
    Amontree JS, Stuart TD, Bredfeldt JE. Autoimmune chronic active hepatitis masquerading as acute hepatitis. J Clin Gastroenterol 1989; 11: 303307.
  • 17
    Maggiore G, Porta G, Bernard O, Hadchouel M, Alvarez F, Homberg JC, Alagille D. Autoimmune hepatitis with initial presentation as acute hepatic failure in young children. J Pediatr 1990; 116: 280282.
  • 18
    Viruet EJ, Torres EA. Steroid therapy in fulminant hepatic failure secondary to autoimmune hepatitis. P R Health Sci J 1998; 17: 297300.
  • 19
    Herzog D, Rasquin-Weber AM, Debray D, Alvarez F. Subfulminant hepatic failure in autoimmune hepatitis type I: an unusual form of presentation. J Hepatol 1997; 27: 578582.
  • 20
    Villamil AG, Casciato P, Eduardo M, Bustos D, Giunta D, Ciardullo M, et al. Fulminant autoimmune hepatitis: Clinical presentation, outcome and prognostic factors. [Abstract 480] Am J Transpl 2005; 5(Suppl 11): 278.
  • 21
    Bosch J, Coll M, Puig A, Espanol T, Ibanez VM, Infante D, Tormo R. Autoimmune hepatitis with fatal outcome. J Pediatr 1990; 118: 823824.
  • 22
    Nikias GA, Batts KP, Czaja AJ. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol 1994; 21: 866871.
  • 23
    Carpenter HA, Czaja AJ. The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants. Clin Liver Dis 2002; 6: 397417.
  • 24
    Sesma P, Alvarez JC, Llinares P, Suarez MD. Disseminated aspergillosis complicating hepatic failure. Arch Intern Med 1984; 144: 861862.
  • 25
    Walsh TJ, Hamilton SR. Disseminated aspergillosis complicating hepatic failure. Arch Intern Med 1983; 143: 11891191.
  • 26
    Okano N, Yamamoto K, Sakaguchi K, Miyake Y, Shimada N, Hakoda T, et al. Clinicopathological features of acute-onset autoimmune hepatitis. Hepatology Res 2003; 25: 263270.
  • 27
    Ferrari R, Pappas G, Agostinelli D, Muratori P, Muratori L, Lenzi M, et al. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of acute type. QJM 2004; 97: 407412.